Understanding the Difference Between Tirzepatide (Mounjaro) and Semaglutide (Wegovy/Ozempic)

GLP-1 and GIP Analogues for Weight Loss:

Semaglutide (Wegovy/Ozempic) and Tirzepatide (Mounjaro) are weekly injectable medications used for effective weight loss, especially when diet and exercise alone haven’t worked. These drugs mimic gut hormones — GLP-1 and GIP — which help regulate appetite, digestion, and blood sugar.

  • Semaglutide targets GLP-1 only, reducing hunger and slowing digestion, with around 15% average weight loss.

  • Tirzepatide targets both GLP-1 and GIP, offering stronger effects on appetite and metabolism, with up to 20%+ weight loss in trials.

Key Differences:

  • Tirzepatide offers more potent weight loss.

  • Both are weekly injections.

  • Side effects include nausea and digestive issues, with Tirzepatide potentially causing slightly more.

Niva Medical Clinic provides personalised, medically supervised weight loss programmes — unlike generic online services — with in-person assessments, GP monitoring, and lifestyle support. They serve patients across North West London and Hertfordshire.

Share this:

Facebook
Twitter
LinkedIn

Recent Posts

cervical cancer awareness month

Cervical Cancer Awareness Month: The Importance of Regular Screenings and HPV Testing at Niva Medical Clinic

Read More

Vitamin D

The Essential Guide to Vitamin D: Testing, Supplementation, and Sunshine Benefits

Read More

men's health

Men’s Health After 40: Testosterone, Heart Health and Erectile Function Explained

Many men begin to notice subtle but persistent changes after the age of 40. Energy levels dip, muscle becomes harder to maintain, recovery slows, mood can flatten, and sexual function may not feel as reliable as it once did. While these changes are often dismissed as “normal ageing”, the reality is more nuanced. Hormonal shifts, particularly in testosterone, interact closely with cardiovascular health, metabolism, mental wellbeing and erectile function.

Read More